Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07148128 |
| Title | Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Auricula Biosciences Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| NEXT Oncology Dallas | RECRUITING | Dallas | Texas | 75230 | United States | Details |
| Next Oncology, San Antonio | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| Princess Margareth Cancer Center | RECRUITING | Toronto | Ontario | Canada | Details | |
| Oxford University Hospital | RECRUITING | Headington | Oxford | 0X3 9DU | United Kingdom | Details |